文献速递肿瘤 PET/CT

前列腺癌生化复发患者行PET/CT检查时左侧腮腺Warthin瘤偶然摄取18F-氟昔洛韦一例

Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer.
PubMed 文献 · Clin Nucl Med · 2020-01-01

一名67岁无症状前列腺癌生化复发男性为再分期行18F-氟昔洛韦PET/CT,静脉注射362.6 MBq(9.8 mCi)后图像显示左侧腮腺小结节状异常摄取增高,超声引导下细针穿刺活检病理符合良性Warthin瘤。

要点

  • 18F-氟昔洛韦PET/CT在前列腺癌生化复发再分期中可偶然发现腮腺Warthin瘤摄取。
  • 左侧腮腺小结节状异常摄取经超声引导下细针穿刺活检证实为良性Warthin瘤。
  • 前列腺癌患者行18F-氟昔洛韦PET/CT时腮腺局灶性摄取需考虑Warthin瘤可能。

核心结论

  • 18F-氟昔洛韦PET/CT检查中左侧腮腺小结节状异常摄取经活检证实为良性Warthin瘤。

研究设计与样本

  • 病例报告:一名67岁无症状前列腺癌生化复发男性为再分期行18F-氟昔洛韦PET/CT。
  • PET/CT扫描范围自大腿近端至颅顶,静脉注射18F-氟昔洛韦362.6 MBq(9.8 mCi)。

主要发现

  • PET/CT显示左侧腮腺一小结节状区域对应18F-氟昔洛韦异常摄取增高灶。
  • 随后超声引导下细针穿刺活检该病灶,组织病理学符合良性Warthin瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 67-year-old asymptomatic man with biochemical recurrent prostate cancer underwent F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. PET/CT images were obtained from the proximal thighs to the vertex of the skull, after the intravenous administration of 362.6 MBq (9.8 mCi) of F-fluciclovine. PET/CT imaging demonstrated a focus of abnormally increased F-fluciclovine uptake corresponding to a small nodularity in the left parotid gland. Subsequent ultrasound-guided fine-needle aspiration biopsy of the lesion revealed histopathology compatible with a benign Warthin tumor.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bitar R, Martiniova L, Bell D, et al. Incidental 18F-Fluciclovine Uptake in a Warthin Tumor of the Parotid Gland in a Patient Undergoing PET/CT Imaging for Biochemical Recurrent Prostate Cancer. Clin Nucl Med. 2020. PMID: 31977491. doi:10.1097/RLU.0000000000002938

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。